Allopurinol is a xanthine oxidase inhibitor that reduces uric acid production by blocking purine catabolism, making it a first-line therapy for chronic gout and hyperuricemia. Simson Pharma's Allopurinol reference standard and impurities support the compendial and stability-indicating testing demanded of this widely prescribed generic.
Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Allopurinol Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.